![\"laim\u012bgs](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/deterioro-cognitivo-puede-ayudar-la-fosfatidilserina-01-1024x573.jpg\")
<\/figure>\n\n\n\n\u0160\u016bnu Membr\u0101nas un Kognit\u012bvie Zaud\u0113jumi<\/strong><\/h2>\n\n\n\nDemence ir termins slim\u012bbu un vesel\u012bas probl\u0113mu grupai, kas izraisa kognit\u012bvo funkciju \u2013 atmi\u0146as, uzved\u012bbas, valodas, probl\u0113mu risin\u0101\u0161anas un l\u0113mumu pie\u0146em\u0161anas \u2013 pasliktin\u0101\u0161anos l\u012bdz t\u0101dam l\u012bmenim, kas trauc\u0113 ikdienas dz\u012bvei.<\/p>\n\n\n\n
Daudzu gadu laik\u0101 p\u0113tnieki atkl\u0101ja vair\u0101kus at\u0161\u0137ir\u012bgus demences c\u0113lo\u0146us, no kuriem vissvar\u012bg\u0101kie bija m\u016bsu smadze\u0146u \u0161\u016bnas ieskaujo\u0161o un aizsarg\u0101jo\u0161o membr\u0101nu strukt\u016bras izmai\u0146as, ko izrais\u012bja neparasti deform\u0113tu prote\u012bnu uzkr\u0101\u0161an\u0101s, izraisot progres\u0113jo\u0161u kognit\u012bvo samazin\u0101\u0161anos.<\/p>\n\n\n\n
Kas ir \u0160\u016bnu Membr\u0101nas?<\/strong><\/h3>\n\n\n\nM\u016bsu \u0161\u016bnu membr\u0101nas sast\u0101v no 2 lip\u012bdu sl\u0101\u0146iem, kas paz\u012bstami k\u0101 lip\u012bdu divsl\u0101nis, un, m\u016bsu \u0161\u016bn\u0101m novecojot, t\u0101s saraujas un main\u0101s lip\u012bdu divsl\u0101\u0146a sast\u0101vs.<\/p>\n\n\n\n
Parasti \u0161\u016bn\u0101m j\u0101b\u016bt briest\u0101m, \u0161\u0137idr\u0101m, veidojam\u0101m un elast\u012bg\u0101m, kas \u013cauj t\u0101m efekt\u012bvi uztvert sinapses sign\u0101lu no cit\u0101m \u0161\u016bn\u0101m, k\u0101 ar\u012b b\u016bt caurlaid\u012bg\u0101m, \u013caujot visiem olbaltumviel\u0101m, fermentiem, bar\u012bbas viel\u0101m, sk\u0101bekli un glikozi utt. lai p\u0101rvietotos kamer\u0101 un no t\u0101s.<\/p>\n\n\n\n
Tom\u0113r, t\u0101 k\u0101 membr\u0101nas zaud\u0113 savu kuplumu un pl\u016bstam\u012bbu, t\u0101s k\u013c\u016bst ciet\u0101kas, t\u0101d\u0113j\u0101di maz\u0101k caurlaid\u012bgas un maz\u0101k sp\u0113j\u012bgas piel\u0101goties sinaptisko sign\u0101lu uztver\u0161anai. J\u016bs varat to uzskat\u012bt par apels\u012bnu, kas s\u0101kas briest un sul\u012bgs, bet, zaud\u0113jot mitrumu, tas k\u013c\u016bst saus\u0101ks un ciet\u0101ks.<\/p>\n\n\n\n
Kas ir lip\u012bdu divsl\u0101\u0146i?<\/strong><\/h3>\n\n\n\n![\"\"](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2018\/02\/phosphatidylserine-the-most-effective-natural-nootropic-01.gif\")
<\/figure>\n\n\n\n<\/strong>\u0160\u016bnu membr\u0101nu fosfolip\u012bdu divsl\u0101nis<\/p>\n\n\n\nLip\u012bdu divsl\u0101\u0146i sast\u0101v no fosfatidilhol\u012bna, fosfatidiletanolam\u012bna, sfingomiel\u012bna (fosfatidilhol\u012bna un fosfatidiletanolam\u012bna kombin\u0101cija), fosfatidilser\u012bna un omega-3 tauksk\u0101bes DHA.<\/p>\n\n\n\n
T\u0101pat k\u0101 fosfatidilhol\u012bns, fosfatidiletanolam\u012bns ir \u013coti svar\u012bgs membr\u0101nas struktur\u0101lajai integrit\u0101tei; nedaudz l\u012bdzin\u0101s \u0113kas t\u0113rauda karkasam, savuk\u0101rt fosfatidilser\u012bns un DHA nodro\u0161ina papildu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n
K\u0101 Noveco\u0161an\u0101s Ietekm\u0113 Lip\u012bdu Divsl\u0101\u0146u Sl\u0101\u0146us?<\/strong><\/h3>\n\n\n\nNovecojot, fosfatidilser\u012bna saturs membr\u0101n\u0101s samazin\u0101s un holester\u012bna saturs palielin\u0101s (1,3). \u0160\u012bs izmai\u0146as ir atsl\u0113ga, lai palielin\u0101tu \u0161\u016bnu membr\u0101nas ciet\u012bbu un samazin\u0101tu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n
Tas izraisa fermentat\u012bv\u0101s aktivit\u0101tes samazin\u0101\u0161anos, un olbaltumvielas un citas uzturvielas vairs nevar viegli iek\u013c\u016bt \u0161\u016bn\u0101 un izk\u013c\u016bt no t\u0101s. T\u0101p\u0113c \u0161\u016bnas vienk\u0101r\u0161i nevar efekt\u012bvi sazin\u0101ties ar cit\u0101m \u0161\u016bn\u0101m (1, 4, 5).<\/p>\n\n\n\n
Par laimi, m\u0113s varam nov\u0113rst \u0161o fosfatidilser\u012bna l\u012bme\u0146a pazemin\u0101\u0161anos, lietojot vienk\u0101r\u0161u fosfatidilser\u012bna piedevu. Fosfatidilser\u012bna piedevas ir viegli uzs\u016bcas (ja vien t\u0101s lieto kop\u0101 ar p\u0101rtiku, kas satur taukus!), k\u0101 ar\u012b viegli \u0161\u0137\u0113rso hematoencef\u0101lisko barjeru smadzen\u0113s, lai t\u0101s var\u0113tu uzs\u016bkties m\u016bsu neironu membr\u0101n\u0101s (6).<\/p>\n\n\n\n
K\u0101 fosfatidilser\u012bns pal\u012bdz ar kognit\u012bvo samazin\u0101\u0161anos?<\/strong><\/h2>\n\n\n\nNok\u013c\u016bstot neironu membr\u0101n\u0101s, fosfatidilser\u012bns var pal\u0113nin\u0101t, aptur\u0113t vai pat main\u012bt notiku\u0161\u0101s struktur\u0101l\u0101s un bio\u0137\u012bmisk\u0101s izmai\u0146as un atjaunot smadze\u0146u \u0161\u016bnu membr\u0101nu elast\u012bbu un pl\u016bstam\u012bbu.<\/p>\n\n\n\n
Tas atbalsta kognit\u012bv\u0101s funkcijas, \u013caujot mums:<\/p>\n\n\n\n
- veidot jaunas \u012bstermi\u0146a atmi\u0146as,<\/li>
- saglab\u0101t ilgtermi\u0146a atmi\u0146as,<\/li>
- k\u0101 ar\u012b atg\u016bt zaud\u0113tas atmi\u0146as<\/li>
- un izveidot piln\u012bgi jaunas.<\/li><\/ul>\n\n\n\n
Tas ar\u012b uzlabo m\u016bsu sp\u0113ju:<\/p>\n\n\n\n
- m\u0101c\u012bties<\/li>
- koncentr\u0113ties<\/li>
- un m\u016bsu sp\u0113ju risin\u0101t probl\u0113mas.<\/li><\/ul>\n\n\n\n
M\u0113s varam uzlabot savas valodas prasmes un sp\u0113ju sazin\u0101ties, k\u0101 ar\u012b kust\u012bbu funkcijas, \u012bpa\u0161i m\u016bsu \u0101tr\u0101s reakcijas un refleksus (6).<\/p>\n\n\n\n
Uztura bag\u0101tin\u0101\u0161ana ar fosfatidilser\u012bnu veicina ar\u012b \u201cNervu Aug\u0161anas Faktors\u201d \u2013 hormona, kas stimul\u0113 jaunu vesel\u012bgu nervu \u0161\u016bnu aug\u0161anu un veco un boj\u0101to nervu \u0161\u016bnu att\u012br\u012b\u0161anu (7). Fosfatidilser\u012bns ar\u012b aizsarg\u0101 membr\u0101nas<\/a> no br\u012bvajiem radik\u0101\u013ciem un oksidat\u012bviem boj\u0101jumiem un stimul\u0113 m\u016bsu pa\u0161u antioksidantu aizsardz\u012bbas sist\u0113mu pieaugumu (8).<\/p>\n\n\n\n![\"jauks](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/deterioro-cognitivo-puede-ayudar-la-fosfatidilserina-02-1024x570.jpg\")
<\/figure>\n\n\n\nP\u0113t\u012bjumi par fosfatidilser\u012bnu, kognit\u012bvo sp\u0113ju zaud\u0113jumiem un trauc\u0113jumiem<\/strong><\/h2>\n\n\n\nP\u0113t\u012bjums #1 \u2013 Atkl\u0101tie p\u0113t\u012bjumi<\/p>\n\n\n\n
Atkl\u0101tos p\u0113t\u012bjumos (t.i., tajos, kuros gan subjekti, gan p\u0113tnieki zina, ka pacienti sa\u0146em fosfatidilser\u012bnu), gados vec\u0101kiem cilv\u0113kiem ar vieglu kognit\u012bvo funkciju pasliktin\u0101\u0161anos 60 dienas tika pievienoti 300 mg fosfatidilser\u012bna (100 mg, 3 reizes dien\u0101).<\/p>\n\n\n\n
60 dienu perioda beig\u0101s subjekti iev\u0113rojami uzlaboja savu sniegumu verb\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, verb\u0101l\u0101s atcer\u0113\u0161an\u0101s, verb\u0101l\u0101s pl\u016bstam\u012bbas, vizu\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, uzman\u012bbas, komunik\u0101cijas prasmju, iniciat\u012bvas, socializ\u0101cijas un pa\u0161pietiekam\u012bbas testos (9,10) 98*+86+.<\/p>\n\n\n\n
P\u0113t\u012bjums #2 \u2013 90 dienu p\u0113t\u012bjums<\/p>\n\n\n\n
Cits p\u0113t\u012bjums pagarin\u0101ja papildin\u0101\u0161anas periodu l\u012bdz 90 dien\u0101m un atkl\u0101ja \u013coti l\u012bdz\u012bgus rezult\u0101tus, bet ar\u012b atkl\u0101ja, ka subjekti uzlaboja vi\u0146u sp\u0113ju atcer\u0113ties v\u0101rdus un atpaz\u012bt sejas (11).<\/p>\n\n\n\n
Cita vec\u0101ka gadag\u0101juma cilv\u0113ku grupa ar smag\u0101ku kognit\u012bvo funkciju samazin\u0101\u0161anos sasniedza iev\u0113rojamus uzlabojumus verb\u0101laj\u0101s sp\u0113j\u0101s, verb\u0101laj\u0101 atmi\u0146\u0101, koncentr\u0113\u0161an\u0101s sp\u0113j\u0101s, modr\u012bb\u0101, iniciat\u012bv\u0101, socializ\u0113\u0161an\u0101 un pa\u0161pietiekam\u012bb\u0101 p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ar t\u0101du pa\u0161u 100 mg fosfatidilser\u012bna devu 3 reizes dien\u0101.<\/p>\n\n\n\n
P\u0113t\u012bjums #3 \u2013 dubultmask\u0113ts p\u0113t\u012bjums<\/p>\n\n\n\n
Dubultakls p\u0113t\u012bjums (t.i., ne subjekti, ne p\u0113tnieki nezina, vai subjekti sa\u0146em fosfatidilser\u012bnu vai placebo) tika veikts gan sieviet\u0113m, gan v\u012brie\u0161iem vecum\u0101 virs 60 gadiem ar vieglu atmi\u0146as zudumu un 300 mg fosfatidilser\u012bna dien\u0101 90 dienas.<\/p>\n\n\n\n
P\u0113tnieki atkl\u0101ja, ka grupai, kas tika papildin\u0101ta ar fosfatidilser\u012bnu, bija iev\u0113rojami uzlabojumi \u012bstermi\u0146a atmi\u0146\u0101, t\u016bl\u012bt\u0113j\u0101 atmi\u0146a, v\u0101rdu kr\u0101juma prasmes, v\u0101rdu atcer\u0113\u0161an\u0101s, uzman\u012bbas sp\u0113ja un modr\u012bba. No otras puses, placebo grupa nesa\u0146\u0113ma nek\u0101du labumu (14).<\/p>\n\n\n\n
P\u0113t\u012bjums #4 \u2013 dubultmask\u0113ts p\u0113t\u012bjums, kas apskata smagus kognit\u012bvos zaud\u0113jumus<\/p>\n\n\n\n
V\u0113l divi dubultmask\u0113ti p\u0113t\u012bjumi bija v\u0113rsti uz cilv\u0113kiem ar smag\u0101kiem kognit\u012bviem trauc\u0113jumiem (14) un vieglu de\u0123enerat\u012bvu demenci (15). P\u0113tnieki atkl\u0101ja, ka vi\u0146iem ir iev\u0113rojami uzlabojusies verb\u0101l\u0101 atmi\u0146a un visp\u0101r\u0113j\u0101 kognit\u012bv\u0101 darb\u012bba. Vi\u0146i ar\u012b konstat\u0113ja, ka p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ir iev\u0113rojami samazin\u0101ta abstinences un ap\u0101tija, sal\u012bdzinot ar placebo grupu.<\/p>\n\n\n\n
Fosfatidilser\u012bna iev\u0113rojamos pan\u0101kumus, lai atbalst\u012btu smadze\u0146u darb\u012bbu un aptur\u0113tu kognit\u012bv\u0101s funkcijas samazin\u0101\u0161anos kl\u012bniskajos p\u0113t\u012bjumos, atzina FDA, kas ir pazi\u0146ojusi:<\/p>\n\n\n\n
- \u201cfosfatidilser\u012bna lieto\u0161ana var samazin\u0101t demences risku gados vec\u0101kiem cilv\u0113kiem\u201d un<\/li>
- \u201cfosfatidilser\u012bna lieto\u0161ana var samazin\u0101t kognit\u012bv\u0101s disfunkcijas risku gados vec\u0101kiem cilv\u0113kiem\u201d (16).<\/li><\/ul>\n\n\n\n
![\"nov\u0113rst](\"https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/deterioro-cognitivo-puede-ayudar-la-fosfatidilserina-03-1024x553.jpg\")
<\/figure>\n\n\n\nBurvju tabletes nepast\u0101v<\/strong><\/h2>\n\n\n\nTom\u0113r j\u0101\u0146em v\u0113r\u0101, ka fosfatidilser\u012bns nav burvju tablete. Tas ir vislab\u0101k piem\u0113rots cilv\u0113kiem, kuri v\u0113las nov\u0113rst izzi\u0146as pasliktin\u0101\u0161anos vai ar viegliem vai vid\u0113ji smagiem kognit\u012bviem trauc\u0113jumiem.<\/p>\n\n\n\n
Piem\u0113ram, cit\u0101 p\u0113t\u012bjum\u0101 galven\u0101 uzman\u012bba tika piev\u0113rsta pacientiem ar Alcheimera slim\u012bbu, kuri papildin\u0101ja ar 400 mg fosfatidilser\u012bna dien\u0101. P\u0113tnieki atkl\u0101ja, ka, lai gan papildin\u0101\u0161ana kop\u0101 ar 16 ned\u0113\u013cu kognit\u012bv\u0101s apm\u0101c\u012bbas programmu rad\u012bja daudz liel\u0101kus uzlabojumus neiropsiholo\u0123iskajos testos, nek\u0101 tikai kognit\u012bv\u0101s apm\u0101c\u012bbas programma, fosfatidilser\u012bns nesp\u0113ja aptur\u0113t slim\u012bbas progresu. Vi\u0146i ar\u012b atkl\u0101ja, ka 4 m\u0113ne\u0161us v\u0113l\u0101k, neskatoties uz nep\u0101rtrauktu fosfatidilser\u012bna papildin\u0101\u0161anu, veiktsp\u0113ja ir pasliktin\u0101jusies (17).\u00a0Ikvienam, kur\u0161 v\u0113las nov\u0113rst izzi\u0146as samazin\u0101\u0161anos vai pal\u012bdz\u0113t aptur\u0113t t\u0101s progresu, m\u0113s iesak\u0101m m\u0113\u0123in\u0101t 100 mg 3 fosfatidilser\u012bna tr\u012bs reizes dien\u0101<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Jo vec\u0101ki m\u0113s k\u013c\u016bstam, jo \u200b\u200bnevesel\u012bg\u0101ki k\u013c\u016bst m\u016bsu neironi. K\u0101d\u0101 br\u012bd\u012b vairums cilv\u0113ku s\u0101k paman\u012bt da\u017eus nelielus simptomus, piem\u0113ram, \u012bstermi\u0146a atmi\u0146a vairs nav tik asa k\u0101 k\u0101dreiz, vai rodas gr\u016bt\u012bbas atcer\u0113ties k\u0101dreiz paz\u012bstamus v\u0101rdus un sejas. T\u0101 ir dabiska noveco\u0161an\u0101s sast\u0101vda\u013ca, un to sauc par kognit\u012bvajiem zaud\u0113jumiem. Laim\u012bg\u0101m, vesel\u0101m smadzen\u0113m un produkt\u012bv\u0101m smadzen\u0113m ir \u0161\u016bnas,…<\/p>\n","protected":false},"author":2,"featured_media":154696,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[2958],"tags":[2977],"coauthors":[],"class_list":["post-230620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uzturs","tag-fosfatidilserins"],"taxonomy_info":{"category":[{"value":2958,"label":"Uzturs"}],"post_tag":[{"value":2977,"label":"fosfatidilser\u012bns"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/declin-cognitif-la-phosphatidylserine-peut-elle-aider-01.jpg",883,476,false],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lv-lv\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":2958,"name":"Uzturs","slug":"uzturs","term_group":0,"term_taxonomy_id":2958,"taxonomy":"category","description":"","parent":0,"count":42,"filter":"raw","cat_ID":2958,"category_count":42,"category_description":"","cat_name":"Uzturs","category_nicename":"uzturs","category_parent":0}],"tag_info":[{"term_id":2977,"name":"fosfatidilser\u012bns","slug":"fosfatidilserins","term_group":0,"term_taxonomy_id":2977,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"}],"wpml":{"language":"lv-lv","is_original":false,"original_post_id":132046,"translations":{"bg-bg":{"id":225770,"language":"bg-bg","is_original":false},"cs-cz":{"id":220931,"language":"cs-cz","is_original":false},"da-dk":{"id":222513,"language":"da-dk","is_original":false},"de-at":{"id":169379,"language":"de-at","is_original":false},"de-de":{"id":146711,"language":"de-de","is_original":false},"el-cy":{"id":229273,"language":"el-cy","is_original":false},"el-gr":{"id":228450,"language":"el-gr","is_original":false},"en-gb":{"id":132046,"language":"en-gb","is_original":true},"en-ie":{"id":166704,"language":"en-ie","is_original":false},"es-es":{"id":74713,"language":"es-es","is_original":false},"et-ee":{"id":230250,"language":"et-ee","is_original":false},"fi-fi":{"id":238665,"language":"fi-fi","is_original":false},"fr-fr":{"id":75037,"language":"fr-fr","is_original":false},"hu-hu":{"id":225141,"language":"hu-hu","is_original":false},"it-it":{"id":146183,"language":"it-it","is_original":false},"lt-lt":{"id":236822,"language":"lt-lt","is_original":false},"lv-lv":{"id":230620,"language":"lv-lv","is_original":false},"nl-nl":{"id":176264,"language":"nl-nl","is_original":false},"ro-ro":{"id":253665,"language":"ro-ro","is_original":false},"sk-sk":{"id":238831,"language":"sk-sk","is_original":false},"sl-si":{"id":239013,"language":"sl-si","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/comments?post=230620"}],"version-history":[{"count":1,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions"}],"predecessor-version":[{"id":230665,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions\/230665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media\/154696"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media?parent=230620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/categories?post=230620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/tags?post=230620"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/coauthors?post=230620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
M\u016bsu \u0161\u016bnu membr\u0101nas sast\u0101v no 2 lip\u012bdu sl\u0101\u0146iem, kas paz\u012bstami k\u0101 lip\u012bdu divsl\u0101nis, un, m\u016bsu \u0161\u016bn\u0101m novecojot, t\u0101s saraujas un main\u0101s lip\u012bdu divsl\u0101\u0146a sast\u0101vs.<\/p>\n\n\n\n
Parasti \u0161\u016bn\u0101m j\u0101b\u016bt briest\u0101m, \u0161\u0137idr\u0101m, veidojam\u0101m un elast\u012bg\u0101m, kas \u013cauj t\u0101m efekt\u012bvi uztvert sinapses sign\u0101lu no cit\u0101m \u0161\u016bn\u0101m, k\u0101 ar\u012b b\u016bt caurlaid\u012bg\u0101m, \u013caujot visiem olbaltumviel\u0101m, fermentiem, bar\u012bbas viel\u0101m, sk\u0101bekli un glikozi utt. lai p\u0101rvietotos kamer\u0101 un no t\u0101s.<\/p>\n\n\n\n
Tom\u0113r, t\u0101 k\u0101 membr\u0101nas zaud\u0113 savu kuplumu un pl\u016bstam\u012bbu, t\u0101s k\u013c\u016bst ciet\u0101kas, t\u0101d\u0113j\u0101di maz\u0101k caurlaid\u012bgas un maz\u0101k sp\u0113j\u012bgas piel\u0101goties sinaptisko sign\u0101lu uztver\u0161anai. J\u016bs varat to uzskat\u012bt par apels\u012bnu, kas s\u0101kas briest un sul\u012bgs, bet, zaud\u0113jot mitrumu, tas k\u013c\u016bst saus\u0101ks un ciet\u0101ks.<\/p>\n\n\n\n
Kas ir lip\u012bdu divsl\u0101\u0146i?<\/strong><\/h3>\n\n\n\n<\/figure>\n\n\n\n<\/strong>\u0160\u016bnu membr\u0101nu fosfolip\u012bdu divsl\u0101nis<\/p>\n\n\n\nLip\u012bdu divsl\u0101\u0146i sast\u0101v no fosfatidilhol\u012bna, fosfatidiletanolam\u012bna, sfingomiel\u012bna (fosfatidilhol\u012bna un fosfatidiletanolam\u012bna kombin\u0101cija), fosfatidilser\u012bna un omega-3 tauksk\u0101bes DHA.<\/p>\n\n\n\n
T\u0101pat k\u0101 fosfatidilhol\u012bns, fosfatidiletanolam\u012bns ir \u013coti svar\u012bgs membr\u0101nas struktur\u0101lajai integrit\u0101tei; nedaudz l\u012bdzin\u0101s \u0113kas t\u0113rauda karkasam, savuk\u0101rt fosfatidilser\u012bns un DHA nodro\u0161ina papildu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n
K\u0101 Noveco\u0161an\u0101s Ietekm\u0113 Lip\u012bdu Divsl\u0101\u0146u Sl\u0101\u0146us?<\/strong><\/h3>\n\n\n\nNovecojot, fosfatidilser\u012bna saturs membr\u0101n\u0101s samazin\u0101s un holester\u012bna saturs palielin\u0101s (1,3). \u0160\u012bs izmai\u0146as ir atsl\u0113ga, lai palielin\u0101tu \u0161\u016bnu membr\u0101nas ciet\u012bbu un samazin\u0101tu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n
Tas izraisa fermentat\u012bv\u0101s aktivit\u0101tes samazin\u0101\u0161anos, un olbaltumvielas un citas uzturvielas vairs nevar viegli iek\u013c\u016bt \u0161\u016bn\u0101 un izk\u013c\u016bt no t\u0101s. T\u0101p\u0113c \u0161\u016bnas vienk\u0101r\u0161i nevar efekt\u012bvi sazin\u0101ties ar cit\u0101m \u0161\u016bn\u0101m (1, 4, 5).<\/p>\n\n\n\n
Par laimi, m\u0113s varam nov\u0113rst \u0161o fosfatidilser\u012bna l\u012bme\u0146a pazemin\u0101\u0161anos, lietojot vienk\u0101r\u0161u fosfatidilser\u012bna piedevu. Fosfatidilser\u012bna piedevas ir viegli uzs\u016bcas (ja vien t\u0101s lieto kop\u0101 ar p\u0101rtiku, kas satur taukus!), k\u0101 ar\u012b viegli \u0161\u0137\u0113rso hematoencef\u0101lisko barjeru smadzen\u0113s, lai t\u0101s var\u0113tu uzs\u016bkties m\u016bsu neironu membr\u0101n\u0101s (6).<\/p>\n\n\n\n
K\u0101 fosfatidilser\u012bns pal\u012bdz ar kognit\u012bvo samazin\u0101\u0161anos?<\/strong><\/h2>\n\n\n\nNok\u013c\u016bstot neironu membr\u0101n\u0101s, fosfatidilser\u012bns var pal\u0113nin\u0101t, aptur\u0113t vai pat main\u012bt notiku\u0161\u0101s struktur\u0101l\u0101s un bio\u0137\u012bmisk\u0101s izmai\u0146as un atjaunot smadze\u0146u \u0161\u016bnu membr\u0101nu elast\u012bbu un pl\u016bstam\u012bbu.<\/p>\n\n\n\n
Tas atbalsta kognit\u012bv\u0101s funkcijas, \u013caujot mums:<\/p>\n\n\n\n
- veidot jaunas \u012bstermi\u0146a atmi\u0146as,<\/li>
- saglab\u0101t ilgtermi\u0146a atmi\u0146as,<\/li>
- k\u0101 ar\u012b atg\u016bt zaud\u0113tas atmi\u0146as<\/li>
- un izveidot piln\u012bgi jaunas.<\/li><\/ul>\n\n\n\n
Tas ar\u012b uzlabo m\u016bsu sp\u0113ju:<\/p>\n\n\n\n
- m\u0101c\u012bties<\/li>
- koncentr\u0113ties<\/li>
- un m\u016bsu sp\u0113ju risin\u0101t probl\u0113mas.<\/li><\/ul>\n\n\n\n
M\u0113s varam uzlabot savas valodas prasmes un sp\u0113ju sazin\u0101ties, k\u0101 ar\u012b kust\u012bbu funkcijas, \u012bpa\u0161i m\u016bsu \u0101tr\u0101s reakcijas un refleksus (6).<\/p>\n\n\n\n
Uztura bag\u0101tin\u0101\u0161ana ar fosfatidilser\u012bnu veicina ar\u012b \u201cNervu Aug\u0161anas Faktors\u201d \u2013 hormona, kas stimul\u0113 jaunu vesel\u012bgu nervu \u0161\u016bnu aug\u0161anu un veco un boj\u0101to nervu \u0161\u016bnu att\u012br\u012b\u0161anu (7). Fosfatidilser\u012bns ar\u012b aizsarg\u0101 membr\u0101nas<\/a> no br\u012bvajiem radik\u0101\u013ciem un oksidat\u012bviem boj\u0101jumiem un stimul\u0113 m\u016bsu pa\u0161u antioksidantu aizsardz\u012bbas sist\u0113mu pieaugumu (8).<\/p>\n\n\n\n<\/figure>\n\n\n\nP\u0113t\u012bjumi par fosfatidilser\u012bnu, kognit\u012bvo sp\u0113ju zaud\u0113jumiem un trauc\u0113jumiem<\/strong><\/h2>\n\n\n\nP\u0113t\u012bjums #1 \u2013 Atkl\u0101tie p\u0113t\u012bjumi<\/p>\n\n\n\n
Atkl\u0101tos p\u0113t\u012bjumos (t.i., tajos, kuros gan subjekti, gan p\u0113tnieki zina, ka pacienti sa\u0146em fosfatidilser\u012bnu), gados vec\u0101kiem cilv\u0113kiem ar vieglu kognit\u012bvo funkciju pasliktin\u0101\u0161anos 60 dienas tika pievienoti 300 mg fosfatidilser\u012bna (100 mg, 3 reizes dien\u0101).<\/p>\n\n\n\n
60 dienu perioda beig\u0101s subjekti iev\u0113rojami uzlaboja savu sniegumu verb\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, verb\u0101l\u0101s atcer\u0113\u0161an\u0101s, verb\u0101l\u0101s pl\u016bstam\u012bbas, vizu\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, uzman\u012bbas, komunik\u0101cijas prasmju, iniciat\u012bvas, socializ\u0101cijas un pa\u0161pietiekam\u012bbas testos (9,10) 98*+86+.<\/p>\n\n\n\n
P\u0113t\u012bjums #2 \u2013 90 dienu p\u0113t\u012bjums<\/p>\n\n\n\n
Cits p\u0113t\u012bjums pagarin\u0101ja papildin\u0101\u0161anas periodu l\u012bdz 90 dien\u0101m un atkl\u0101ja \u013coti l\u012bdz\u012bgus rezult\u0101tus, bet ar\u012b atkl\u0101ja, ka subjekti uzlaboja vi\u0146u sp\u0113ju atcer\u0113ties v\u0101rdus un atpaz\u012bt sejas (11).<\/p>\n\n\n\n
Cita vec\u0101ka gadag\u0101juma cilv\u0113ku grupa ar smag\u0101ku kognit\u012bvo funkciju samazin\u0101\u0161anos sasniedza iev\u0113rojamus uzlabojumus verb\u0101laj\u0101s sp\u0113j\u0101s, verb\u0101laj\u0101 atmi\u0146\u0101, koncentr\u0113\u0161an\u0101s sp\u0113j\u0101s, modr\u012bb\u0101, iniciat\u012bv\u0101, socializ\u0113\u0161an\u0101 un pa\u0161pietiekam\u012bb\u0101 p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ar t\u0101du pa\u0161u 100 mg fosfatidilser\u012bna devu 3 reizes dien\u0101.<\/p>\n\n\n\n
P\u0113t\u012bjums #3 \u2013 dubultmask\u0113ts p\u0113t\u012bjums<\/p>\n\n\n\n
Dubultakls p\u0113t\u012bjums (t.i., ne subjekti, ne p\u0113tnieki nezina, vai subjekti sa\u0146em fosfatidilser\u012bnu vai placebo) tika veikts gan sieviet\u0113m, gan v\u012brie\u0161iem vecum\u0101 virs 60 gadiem ar vieglu atmi\u0146as zudumu un 300 mg fosfatidilser\u012bna dien\u0101 90 dienas.<\/p>\n\n\n\n
P\u0113tnieki atkl\u0101ja, ka grupai, kas tika papildin\u0101ta ar fosfatidilser\u012bnu, bija iev\u0113rojami uzlabojumi \u012bstermi\u0146a atmi\u0146\u0101, t\u016bl\u012bt\u0113j\u0101 atmi\u0146a, v\u0101rdu kr\u0101juma prasmes, v\u0101rdu atcer\u0113\u0161an\u0101s, uzman\u012bbas sp\u0113ja un modr\u012bba. No otras puses, placebo grupa nesa\u0146\u0113ma nek\u0101du labumu (14).<\/p>\n\n\n\n
P\u0113t\u012bjums #4 \u2013 dubultmask\u0113ts p\u0113t\u012bjums, kas apskata smagus kognit\u012bvos zaud\u0113jumus<\/p>\n\n\n\n
V\u0113l divi dubultmask\u0113ti p\u0113t\u012bjumi bija v\u0113rsti uz cilv\u0113kiem ar smag\u0101kiem kognit\u012bviem trauc\u0113jumiem (14) un vieglu de\u0123enerat\u012bvu demenci (15). P\u0113tnieki atkl\u0101ja, ka vi\u0146iem ir iev\u0113rojami uzlabojusies verb\u0101l\u0101 atmi\u0146a un visp\u0101r\u0113j\u0101 kognit\u012bv\u0101 darb\u012bba. Vi\u0146i ar\u012b konstat\u0113ja, ka p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ir iev\u0113rojami samazin\u0101ta abstinences un ap\u0101tija, sal\u012bdzinot ar placebo grupu.<\/p>\n\n\n\n
Fosfatidilser\u012bna iev\u0113rojamos pan\u0101kumus, lai atbalst\u012btu smadze\u0146u darb\u012bbu un aptur\u0113tu kognit\u012bv\u0101s funkcijas samazin\u0101\u0161anos kl\u012bniskajos p\u0113t\u012bjumos, atzina FDA, kas ir pazi\u0146ojusi:<\/p>\n\n\n\n
- \u201cfosfatidilser\u012bna lieto\u0161ana var samazin\u0101t demences risku gados vec\u0101kiem cilv\u0113kiem\u201d un<\/li>
- \u201cfosfatidilser\u012bna lieto\u0161ana var samazin\u0101t kognit\u012bv\u0101s disfunkcijas risku gados vec\u0101kiem cilv\u0113kiem\u201d (16).<\/li><\/ul>\n\n\n\n
<\/figure>\n\n\n\nBurvju tabletes nepast\u0101v<\/strong><\/h2>\n\n\n\nTom\u0113r j\u0101\u0146em v\u0113r\u0101, ka fosfatidilser\u012bns nav burvju tablete. Tas ir vislab\u0101k piem\u0113rots cilv\u0113kiem, kuri v\u0113las nov\u0113rst izzi\u0146as pasliktin\u0101\u0161anos vai ar viegliem vai vid\u0113ji smagiem kognit\u012bviem trauc\u0113jumiem.<\/p>\n\n\n\n
Piem\u0113ram, cit\u0101 p\u0113t\u012bjum\u0101 galven\u0101 uzman\u012bba tika piev\u0113rsta pacientiem ar Alcheimera slim\u012bbu, kuri papildin\u0101ja ar 400 mg fosfatidilser\u012bna dien\u0101. P\u0113tnieki atkl\u0101ja, ka, lai gan papildin\u0101\u0161ana kop\u0101 ar 16 ned\u0113\u013cu kognit\u012bv\u0101s apm\u0101c\u012bbas programmu rad\u012bja daudz liel\u0101kus uzlabojumus neiropsiholo\u0123iskajos testos, nek\u0101 tikai kognit\u012bv\u0101s apm\u0101c\u012bbas programma, fosfatidilser\u012bns nesp\u0113ja aptur\u0113t slim\u012bbas progresu. Vi\u0146i ar\u012b atkl\u0101ja, ka 4 m\u0113ne\u0161us v\u0113l\u0101k, neskatoties uz nep\u0101rtrauktu fosfatidilser\u012bna papildin\u0101\u0161anu, veiktsp\u0113ja ir pasliktin\u0101jusies (17).\u00a0Ikvienam, kur\u0161 v\u0113las nov\u0113rst izzi\u0146as samazin\u0101\u0161anos vai pal\u012bdz\u0113t aptur\u0113t t\u0101s progresu, m\u0113s iesak\u0101m m\u0113\u0123in\u0101t 100 mg 3 fosfatidilser\u012bna tr\u012bs reizes dien\u0101<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Jo vec\u0101ki m\u0113s k\u013c\u016bstam, jo \u200b\u200bnevesel\u012bg\u0101ki k\u013c\u016bst m\u016bsu neironi. K\u0101d\u0101 br\u012bd\u012b vairums cilv\u0113ku s\u0101k paman\u012bt da\u017eus nelielus simptomus, piem\u0113ram, \u012bstermi\u0146a atmi\u0146a vairs nav tik asa k\u0101 k\u0101dreiz, vai rodas gr\u016bt\u012bbas atcer\u0113ties k\u0101dreiz paz\u012bstamus v\u0101rdus un sejas. T\u0101 ir dabiska noveco\u0161an\u0101s sast\u0101vda\u013ca, un to sauc par kognit\u012bvajiem zaud\u0113jumiem. Laim\u012bg\u0101m, vesel\u0101m smadzen\u0113m un produkt\u012bv\u0101m smadzen\u0113m ir \u0161\u016bnas,…<\/p>\n","protected":false},"author":2,"featured_media":154696,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[2958],"tags":[2977],"coauthors":[],"class_list":["post-230620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uzturs","tag-fosfatidilserins"],"taxonomy_info":{"category":[{"value":2958,"label":"Uzturs"}],"post_tag":[{"value":2977,"label":"fosfatidilser\u012bns"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/declin-cognitif-la-phosphatidylserine-peut-elle-aider-01.jpg",883,476,false],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lv-lv\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":2958,"name":"Uzturs","slug":"uzturs","term_group":0,"term_taxonomy_id":2958,"taxonomy":"category","description":"","parent":0,"count":42,"filter":"raw","cat_ID":2958,"category_count":42,"category_description":"","cat_name":"Uzturs","category_nicename":"uzturs","category_parent":0}],"tag_info":[{"term_id":2977,"name":"fosfatidilser\u012bns","slug":"fosfatidilserins","term_group":0,"term_taxonomy_id":2977,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"}],"wpml":{"language":"lv-lv","is_original":false,"original_post_id":132046,"translations":{"bg-bg":{"id":225770,"language":"bg-bg","is_original":false},"cs-cz":{"id":220931,"language":"cs-cz","is_original":false},"da-dk":{"id":222513,"language":"da-dk","is_original":false},"de-at":{"id":169379,"language":"de-at","is_original":false},"de-de":{"id":146711,"language":"de-de","is_original":false},"el-cy":{"id":229273,"language":"el-cy","is_original":false},"el-gr":{"id":228450,"language":"el-gr","is_original":false},"en-gb":{"id":132046,"language":"en-gb","is_original":true},"en-ie":{"id":166704,"language":"en-ie","is_original":false},"es-es":{"id":74713,"language":"es-es","is_original":false},"et-ee":{"id":230250,"language":"et-ee","is_original":false},"fi-fi":{"id":238665,"language":"fi-fi","is_original":false},"fr-fr":{"id":75037,"language":"fr-fr","is_original":false},"hu-hu":{"id":225141,"language":"hu-hu","is_original":false},"it-it":{"id":146183,"language":"it-it","is_original":false},"lt-lt":{"id":236822,"language":"lt-lt","is_original":false},"lv-lv":{"id":230620,"language":"lv-lv","is_original":false},"nl-nl":{"id":176264,"language":"nl-nl","is_original":false},"ro-ro":{"id":253665,"language":"ro-ro","is_original":false},"sk-sk":{"id":238831,"language":"sk-sk","is_original":false},"sl-si":{"id":239013,"language":"sl-si","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/comments?post=230620"}],"version-history":[{"count":1,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions"}],"predecessor-version":[{"id":230665,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions\/230665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media\/154696"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media?parent=230620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/categories?post=230620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/tags?post=230620"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/coauthors?post=230620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/figure>\n\n\n\n<\/strong>\u0160\u016bnu membr\u0101nu fosfolip\u012bdu divsl\u0101nis<\/p>\n\n\n\n Lip\u012bdu divsl\u0101\u0146i sast\u0101v no fosfatidilhol\u012bna, fosfatidiletanolam\u012bna, sfingomiel\u012bna (fosfatidilhol\u012bna un fosfatidiletanolam\u012bna kombin\u0101cija), fosfatidilser\u012bna un omega-3 tauksk\u0101bes DHA.<\/p>\n\n\n\n T\u0101pat k\u0101 fosfatidilhol\u012bns, fosfatidiletanolam\u012bns ir \u013coti svar\u012bgs membr\u0101nas struktur\u0101lajai integrit\u0101tei; nedaudz l\u012bdzin\u0101s \u0113kas t\u0113rauda karkasam, savuk\u0101rt fosfatidilser\u012bns un DHA nodro\u0161ina papildu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n Novecojot, fosfatidilser\u012bna saturs membr\u0101n\u0101s samazin\u0101s un holester\u012bna saturs palielin\u0101s (1,3). \u0160\u012bs izmai\u0146as ir atsl\u0113ga, lai palielin\u0101tu \u0161\u016bnu membr\u0101nas ciet\u012bbu un samazin\u0101tu pl\u016bstam\u012bbu un elast\u012bbu.<\/p>\n\n\n\n Tas izraisa fermentat\u012bv\u0101s aktivit\u0101tes samazin\u0101\u0161anos, un olbaltumvielas un citas uzturvielas vairs nevar viegli iek\u013c\u016bt \u0161\u016bn\u0101 un izk\u013c\u016bt no t\u0101s. T\u0101p\u0113c \u0161\u016bnas vienk\u0101r\u0161i nevar efekt\u012bvi sazin\u0101ties ar cit\u0101m \u0161\u016bn\u0101m (1, 4, 5).<\/p>\n\n\n\n Par laimi, m\u0113s varam nov\u0113rst \u0161o fosfatidilser\u012bna l\u012bme\u0146a pazemin\u0101\u0161anos, lietojot vienk\u0101r\u0161u fosfatidilser\u012bna piedevu. Fosfatidilser\u012bna piedevas ir viegli uzs\u016bcas (ja vien t\u0101s lieto kop\u0101 ar p\u0101rtiku, kas satur taukus!), k\u0101 ar\u012b viegli \u0161\u0137\u0113rso hematoencef\u0101lisko barjeru smadzen\u0113s, lai t\u0101s var\u0113tu uzs\u016bkties m\u016bsu neironu membr\u0101n\u0101s (6).<\/p>\n\n\n\n Nok\u013c\u016bstot neironu membr\u0101n\u0101s, fosfatidilser\u012bns var pal\u0113nin\u0101t, aptur\u0113t vai pat main\u012bt notiku\u0161\u0101s struktur\u0101l\u0101s un bio\u0137\u012bmisk\u0101s izmai\u0146as un atjaunot smadze\u0146u \u0161\u016bnu membr\u0101nu elast\u012bbu un pl\u016bstam\u012bbu.<\/p>\n\n\n\n Tas atbalsta kognit\u012bv\u0101s funkcijas, \u013caujot mums:<\/p>\n\n\n\n Tas ar\u012b uzlabo m\u016bsu sp\u0113ju:<\/p>\n\n\n\n M\u0113s varam uzlabot savas valodas prasmes un sp\u0113ju sazin\u0101ties, k\u0101 ar\u012b kust\u012bbu funkcijas, \u012bpa\u0161i m\u016bsu \u0101tr\u0101s reakcijas un refleksus (6).<\/p>\n\n\n\n Uztura bag\u0101tin\u0101\u0161ana ar fosfatidilser\u012bnu veicina ar\u012b \u201cNervu Aug\u0161anas Faktors\u201d \u2013 hormona, kas stimul\u0113 jaunu vesel\u012bgu nervu \u0161\u016bnu aug\u0161anu un veco un boj\u0101to nervu \u0161\u016bnu att\u012br\u012b\u0161anu (7). Fosfatidilser\u012bns ar\u012b aizsarg\u0101 membr\u0101nas<\/a> no br\u012bvajiem radik\u0101\u013ciem un oksidat\u012bviem boj\u0101jumiem un stimul\u0113 m\u016bsu pa\u0161u antioksidantu aizsardz\u012bbas sist\u0113mu pieaugumu (8).<\/p>\n\n\n\n P\u0113t\u012bjums #1 \u2013 Atkl\u0101tie p\u0113t\u012bjumi<\/p>\n\n\n\n Atkl\u0101tos p\u0113t\u012bjumos (t.i., tajos, kuros gan subjekti, gan p\u0113tnieki zina, ka pacienti sa\u0146em fosfatidilser\u012bnu), gados vec\u0101kiem cilv\u0113kiem ar vieglu kognit\u012bvo funkciju pasliktin\u0101\u0161anos 60 dienas tika pievienoti 300 mg fosfatidilser\u012bna (100 mg, 3 reizes dien\u0101).<\/p>\n\n\n\n 60 dienu perioda beig\u0101s subjekti iev\u0113rojami uzlaboja savu sniegumu verb\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, verb\u0101l\u0101s atcer\u0113\u0161an\u0101s, verb\u0101l\u0101s pl\u016bstam\u012bbas, vizu\u0101l\u0101s m\u0101c\u012b\u0161an\u0101s, uzman\u012bbas, komunik\u0101cijas prasmju, iniciat\u012bvas, socializ\u0101cijas un pa\u0161pietiekam\u012bbas testos (9,10) 98*+86+.<\/p>\n\n\n\n P\u0113t\u012bjums #2 \u2013 90 dienu p\u0113t\u012bjums<\/p>\n\n\n\n Cits p\u0113t\u012bjums pagarin\u0101ja papildin\u0101\u0161anas periodu l\u012bdz 90 dien\u0101m un atkl\u0101ja \u013coti l\u012bdz\u012bgus rezult\u0101tus, bet ar\u012b atkl\u0101ja, ka subjekti uzlaboja vi\u0146u sp\u0113ju atcer\u0113ties v\u0101rdus un atpaz\u012bt sejas (11).<\/p>\n\n\n\n Cita vec\u0101ka gadag\u0101juma cilv\u0113ku grupa ar smag\u0101ku kognit\u012bvo funkciju samazin\u0101\u0161anos sasniedza iev\u0113rojamus uzlabojumus verb\u0101laj\u0101s sp\u0113j\u0101s, verb\u0101laj\u0101 atmi\u0146\u0101, koncentr\u0113\u0161an\u0101s sp\u0113j\u0101s, modr\u012bb\u0101, iniciat\u012bv\u0101, socializ\u0113\u0161an\u0101 un pa\u0161pietiekam\u012bb\u0101 p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ar t\u0101du pa\u0161u 100 mg fosfatidilser\u012bna devu 3 reizes dien\u0101.<\/p>\n\n\n\n P\u0113t\u012bjums #3 \u2013 dubultmask\u0113ts p\u0113t\u012bjums<\/p>\n\n\n\n Dubultakls p\u0113t\u012bjums (t.i., ne subjekti, ne p\u0113tnieki nezina, vai subjekti sa\u0146em fosfatidilser\u012bnu vai placebo) tika veikts gan sieviet\u0113m, gan v\u012brie\u0161iem vecum\u0101 virs 60 gadiem ar vieglu atmi\u0146as zudumu un 300 mg fosfatidilser\u012bna dien\u0101 90 dienas.<\/p>\n\n\n\n P\u0113tnieki atkl\u0101ja, ka grupai, kas tika papildin\u0101ta ar fosfatidilser\u012bnu, bija iev\u0113rojami uzlabojumi \u012bstermi\u0146a atmi\u0146\u0101, t\u016bl\u012bt\u0113j\u0101 atmi\u0146a, v\u0101rdu kr\u0101juma prasmes, v\u0101rdu atcer\u0113\u0161an\u0101s, uzman\u012bbas sp\u0113ja un modr\u012bba. No otras puses, placebo grupa nesa\u0146\u0113ma nek\u0101du labumu (14).<\/p>\n\n\n\n P\u0113t\u012bjums #4 \u2013 dubultmask\u0113ts p\u0113t\u012bjums, kas apskata smagus kognit\u012bvos zaud\u0113jumus<\/p>\n\n\n\n V\u0113l divi dubultmask\u0113ti p\u0113t\u012bjumi bija v\u0113rsti uz cilv\u0113kiem ar smag\u0101kiem kognit\u012bviem trauc\u0113jumiem (14) un vieglu de\u0123enerat\u012bvu demenci (15). P\u0113tnieki atkl\u0101ja, ka vi\u0146iem ir iev\u0113rojami uzlabojusies verb\u0101l\u0101 atmi\u0146a un visp\u0101r\u0113j\u0101 kognit\u012bv\u0101 darb\u012bba. Vi\u0146i ar\u012b konstat\u0113ja, ka p\u0113c fosfatidilser\u012bna papildin\u0101\u0161anas ir iev\u0113rojami samazin\u0101ta abstinences un ap\u0101tija, sal\u012bdzinot ar placebo grupu.<\/p>\n\n\n\n Fosfatidilser\u012bna iev\u0113rojamos pan\u0101kumus, lai atbalst\u012btu smadze\u0146u darb\u012bbu un aptur\u0113tu kognit\u012bv\u0101s funkcijas samazin\u0101\u0161anos kl\u012bniskajos p\u0113t\u012bjumos, atzina FDA, kas ir pazi\u0146ojusi:<\/p>\n\n\n\n Tom\u0113r j\u0101\u0146em v\u0113r\u0101, ka fosfatidilser\u012bns nav burvju tablete. Tas ir vislab\u0101k piem\u0113rots cilv\u0113kiem, kuri v\u0113las nov\u0113rst izzi\u0146as pasliktin\u0101\u0161anos vai ar viegliem vai vid\u0113ji smagiem kognit\u012bviem trauc\u0113jumiem.<\/p>\n\n\n\n Piem\u0113ram, cit\u0101 p\u0113t\u012bjum\u0101 galven\u0101 uzman\u012bba tika piev\u0113rsta pacientiem ar Alcheimera slim\u012bbu, kuri papildin\u0101ja ar 400 mg fosfatidilser\u012bna dien\u0101. P\u0113tnieki atkl\u0101ja, ka, lai gan papildin\u0101\u0161ana kop\u0101 ar 16 ned\u0113\u013cu kognit\u012bv\u0101s apm\u0101c\u012bbas programmu rad\u012bja daudz liel\u0101kus uzlabojumus neiropsiholo\u0123iskajos testos, nek\u0101 tikai kognit\u012bv\u0101s apm\u0101c\u012bbas programma, fosfatidilser\u012bns nesp\u0113ja aptur\u0113t slim\u012bbas progresu. Vi\u0146i ar\u012b atkl\u0101ja, ka 4 m\u0113ne\u0161us v\u0113l\u0101k, neskatoties uz nep\u0101rtrauktu fosfatidilser\u012bna papildin\u0101\u0161anu, veiktsp\u0113ja ir pasliktin\u0101jusies (17).\u00a0Ikvienam, kur\u0161 v\u0113las nov\u0113rst izzi\u0146as samazin\u0101\u0161anos vai pal\u012bdz\u0113t aptur\u0113t t\u0101s progresu, m\u0113s iesak\u0101m m\u0113\u0123in\u0101t 100 mg 3 fosfatidilser\u012bna tr\u012bs reizes dien\u0101<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Jo vec\u0101ki m\u0113s k\u013c\u016bstam, jo \u200b\u200bnevesel\u012bg\u0101ki k\u013c\u016bst m\u016bsu neironi. K\u0101d\u0101 br\u012bd\u012b vairums cilv\u0113ku s\u0101k paman\u012bt da\u017eus nelielus simptomus, piem\u0113ram, \u012bstermi\u0146a atmi\u0146a vairs nav tik asa k\u0101 k\u0101dreiz, vai rodas gr\u016bt\u012bbas atcer\u0113ties k\u0101dreiz paz\u012bstamus v\u0101rdus un sejas. T\u0101 ir dabiska noveco\u0161an\u0101s sast\u0101vda\u013ca, un to sauc par kognit\u012bvajiem zaud\u0113jumiem. Laim\u012bg\u0101m, vesel\u0101m smadzen\u0113m un produkt\u012bv\u0101m smadzen\u0113m ir \u0161\u016bnas,…<\/p>\n","protected":false},"author":2,"featured_media":154696,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[2958],"tags":[2977],"coauthors":[],"class_list":["post-230620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uzturs","tag-fosfatidilserins"],"taxonomy_info":{"category":[{"value":2958,"label":"Uzturs"}],"post_tag":[{"value":2977,"label":"fosfatidilser\u012bns"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2025\/07\/declin-cognitif-la-phosphatidylserine-peut-elle-aider-01.jpg",883,476,false],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lv-lv\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":2958,"name":"Uzturs","slug":"uzturs","term_group":0,"term_taxonomy_id":2958,"taxonomy":"category","description":"","parent":0,"count":42,"filter":"raw","cat_ID":2958,"category_count":42,"category_description":"","cat_name":"Uzturs","category_nicename":"uzturs","category_parent":0}],"tag_info":[{"term_id":2977,"name":"fosfatidilser\u012bns","slug":"fosfatidilserins","term_group":0,"term_taxonomy_id":2977,"taxonomy":"post_tag","description":"","parent":0,"count":2,"filter":"raw"}],"wpml":{"language":"lv-lv","is_original":false,"original_post_id":132046,"translations":{"bg-bg":{"id":225770,"language":"bg-bg","is_original":false},"cs-cz":{"id":220931,"language":"cs-cz","is_original":false},"da-dk":{"id":222513,"language":"da-dk","is_original":false},"de-at":{"id":169379,"language":"de-at","is_original":false},"de-de":{"id":146711,"language":"de-de","is_original":false},"el-cy":{"id":229273,"language":"el-cy","is_original":false},"el-gr":{"id":228450,"language":"el-gr","is_original":false},"en-gb":{"id":132046,"language":"en-gb","is_original":true},"en-ie":{"id":166704,"language":"en-ie","is_original":false},"es-es":{"id":74713,"language":"es-es","is_original":false},"et-ee":{"id":230250,"language":"et-ee","is_original":false},"fi-fi":{"id":238665,"language":"fi-fi","is_original":false},"fr-fr":{"id":75037,"language":"fr-fr","is_original":false},"hu-hu":{"id":225141,"language":"hu-hu","is_original":false},"it-it":{"id":146183,"language":"it-it","is_original":false},"lt-lt":{"id":236822,"language":"lt-lt","is_original":false},"lv-lv":{"id":230620,"language":"lv-lv","is_original":false},"nl-nl":{"id":176264,"language":"nl-nl","is_original":false},"ro-ro":{"id":253665,"language":"ro-ro","is_original":false},"sk-sk":{"id":238831,"language":"sk-sk","is_original":false},"sl-si":{"id":239013,"language":"sl-si","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/comments?post=230620"}],"version-history":[{"count":1,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions"}],"predecessor-version":[{"id":230665,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230620\/revisions\/230665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media\/154696"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media?parent=230620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/categories?post=230620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/tags?post=230620"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/coauthors?post=230620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}K\u0101 Noveco\u0161an\u0101s Ietekm\u0113 Lip\u012bdu Divsl\u0101\u0146u Sl\u0101\u0146us?<\/strong><\/h3>\n\n\n\n
K\u0101 fosfatidilser\u012bns pal\u012bdz ar kognit\u012bvo samazin\u0101\u0161anos?<\/strong><\/h2>\n\n\n\n
<\/figure>\n\n\n\nP\u0113t\u012bjumi par fosfatidilser\u012bnu, kognit\u012bvo sp\u0113ju zaud\u0113jumiem un trauc\u0113jumiem<\/strong><\/h2>\n\n\n\n
<\/figure>\n\n\n\nBurvju tabletes nepast\u0101v<\/strong><\/h2>\n\n\n\n